Pfizer’s Kindler elected PhRMA chairman
Published on: 22/03/10
Jeffrey Kindler, chairman and chief executive of Pfizer, has been elected chairman of PhRMA, succeeding AstraZeneca’s chief executive David Brennan in the role.
“I am excited to lead this organisation during such a dynamic time for our nation’s healthcare system,” Kindler said. “The biopharmaceutical industry can be a catalyst for change by creating a future with good jobs and good health in the US.”
“We aim to be a leading voice for improving everyone’s ability to have reliable and affordable health care.”
The US industry association has also elected Sanofi-Aventis chief executive Chris Viehbacher as chairman-elect of the board of directors and Lilly chief executive John Lechleiter as board treasurer.
Meanwhile, PhRMA president and chief executive Billy Tauzin will be stepping down at the end of June after five years of heading up the association, but plans to continue in a consultancy role.
Mission Statement
InPharm.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma jobs, pharma events, and pharma service company listings.
Site content is produced by our editorial team for InPharm.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches
